LeonaBio (LONA) Research & Development (2019 - 2026)

LeonaBio (LONA) has 8 years of Research & Development data on file, last reported at $11.3 million in Q1 2026.

• On a quarterly basis, Research & Development rose 161.79% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $24.5 million, a 54.49% decrease from a year earlier, with the FY2025 full-year figure at $17.5 million, down 75.24% from the prior year.
• Research & Development for Q1 2026 stood at $11.3 million, up from $6.7 million in the prior quarter.
• Over the last five years, Research & Development for LONA reached as high as $27.2 million in Q3 2023 and fell as low as $2.8 million in Q3 2025.
• Historically, Research & Development has averaged $15.0 million across 5 years, with a median of $15.2 million in 2022.
• Across the five-year window, Research & Development sank 84.24% in 2025 and soared 161.79% in 2026, its largest moves.
• Year by year, Research & Development stood at $15.2 million in 2022, then jumped by 55.42% to $23.7 million in 2023, then tumbled by 60.43% to $9.4 million in 2024, then retreated by 28.37% to $6.7 million in 2025, then jumped by 67.79% to $11.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $11.3 million in Q1 2026, $6.7 million in Q4 2025, and $2.8 million in Q3 2025.